Estelle Cauchin
Overview
Explore the profile of Estelle Cauchin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
205
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Le Bras P, Cauchin E, De Lange G, Moussata D, Garcia G, Queneherve L, et al.
Clin Gastroenterol Hepatol
. 2024 Mar;
22(9):1839-1846.e1.
PMID: 38555039
Background & Aims: The majority of patients with familial adenomatous polyposis (FAP) develop duodenal adenomas with a risk of progression to duodenal cancer. Endoscopic management of FAP duodenal adenomas has...
2.
Pizzanelli S, Cauchin E, Bossard C, Galmiche L
Ann Pathol
. 2022 Sep;
42(6):488-490.
PMID: 36163108
No abstract available.
3.
Nizet P, Touchefeu Y, Pecout S, Cauchin E, Beaudouin E, Mayol S, et al.
Support Care Cancer
. 2021 Nov;
30(3):2591-2604.
PMID: 34812952
Purpose: The aim of this study was to explore the beliefs, perceptions and representations of patients in order to identify the determinants of oral anticancer drugs adherence and to take...
4.
Pierre-Noel E, Airaud F, Cauchin E, Garrec C, Ricordeau I, Michon C, et al.
Fam Cancer
. 2021 Sep;
21(3):319-324.
PMID: 34519923
Lynch syndrome (LS) is a condition which predisposes individuals primarily to early-onset colorectal and endometrial cancer. LS is characterized by a germline pathogenic variant in one of the MMR (MisMatch...
5.
Perkhofer L, Golan T, Cuyle P, Matysiak-Budnik T, Van Laethem J, Macarulla T, et al.
Cancers (Basel)
. 2021 Sep;
13(17).
PMID: 34503069
Impaired DNA damage repair (DDR) is increasingly recognised as a hallmark in pancreatic ductal adenocarcinoma (PDAC). It is estimated that around 14% of human PDACs harbour mutations in genes involved...
6.
Horgan D, Ciliberto G, Conte P, Baldwin D, Seijo L, Montuenga L, et al.
Biomed Hub
. 2021 Feb;
5(3):182-223.
PMID: 33564664
Rapid and continuing advances in biomarker testing are not being matched by take-up in health systems, and this is hampering both patient care and innovation. It also risks costing health...
7.
Chapelle N, Peron M, Queneherve L, Bourget A, Leroy M, Touchefeu Y, et al.
Clin Transl Gastroenterol
. 2021 Jan;
11(12):e00237.
PMID: 33512802
Introduction: Data on the evolution of gastric precancerous lesions (GPL), especially in countries of a Low gastric cancer incidence area are limited. Our objective was to study a long-term evolution...
8.
Chapelle N, Jirka I, Peron M, Queneherve L, Cauchin E, Touchefeu Y, et al.
Gastrointest Tumors
. 2020 Nov;
7(4):110-116.
PMID: 33173774
Background: Surveillance of gastric precancerous lesions (GPL) may reduce gastric cancer (GC)-related mortality, but some patients with GPL are lost to follow-up. Objective: The aim of this study was to...
9.
Hulo P, Touchefeu Y, Cauchin E, Archambeaud I, Chapelle N, Bossard C, et al.
Clin Colorectal Cancer
. 2020 Jul;
19(4):e183-e188.
PMID: 32703755
No abstract available.
10.
Chapelle N, Peron M, Mosnier J, Queneherve L, Coron E, Bourget A, et al.
Dig Dis
. 2019 Oct;
38(4):286-292.
PMID: 31655807
Introduction: Surveillance of gastric precancerous lesions (GPL) is recommended, but the data on their clinical and endoscopic management in a "real-life" practice are limited. Our aim was to study the...